Cargando…
Recent progress on rapid SARS-CoV-2/COVID-19 detection by CRISPR-Cas13-based platforms
The limitations of conventional diagnostic procedures, such as real-time PCR-based methods and serological tests, have led the scientific community to innovate alternative nucleic acid detection approaches for SARS-CoV-2 RNA, thereby addressing the dire need for increased testing. Such approaches ai...
Autor principal: | Aquino-Jarquin, Guillermo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216859/ https://www.ncbi.nlm.nih.gov/pubmed/34147688 http://dx.doi.org/10.1016/j.drudis.2021.06.005 |
Ejemplares similares
-
Nanosponges: An overlooked promising strategy to combat SARS-CoV-2
por: Mostafavi, Ebrahim, et al.
Publicado: (2022) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021) -
Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022) -
High‐throughput screening assays for SARS‐CoV‐2 drug development: Current status and future directions
por: Xu, Tuan, et al.
Publicado: (2021) -
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022)